(Q34207158)

31 July 2017

Effect of including nonfatal events in cardiovascular risk estimation, illustrated with data from The Netherlands (English)

1 reference

31 July 2017

0 references

1 reference

Yvonne T van der Schouw

object named as

Yvonne T van der Schouw

series ordinal

7

0 references

Diederick Grobbee

series ordinal

6

object named as

Diederick E Grobbee

1 reference

31 July 2017

2

Johanna M Geleijnse

1 reference

31 July 2017

8

Wm Monique Verschuren

1 reference

31 July 2017

3

Jolanda Ma Boer

1 reference

31 July 2017

5

Hendriek Boshuizen

1 reference

31 July 2017

4

Daan Kromhout

1 reference

31 July 2017

Ineke van Dis

1

1 reference

31 July 2017

22 March 2012

1 reference

European Journal of Preventive Cardiology

31 July 2017

1 reference

31 July 2017

21

1 reference

31 July 2017

3

1 reference

31 July 2017

377-383

1 reference

Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension

31 July 2017

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Framingham risk function overestimates risk of coronary heart disease in men and women from Germany—results from the MONICA Augsburg and the PROCAM cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

An updated coronary risk profile. A statement for health professionals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Prediction of Coronary Heart Disease Using Risk Factor Categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Cardiovascular risk prediction: basic concepts, current status, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Is acute myocardial infarction disappearing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

The reliability of cause-of-death coding in The Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Validity of coronary heart diseases and heart failure based on hospital discharge and mortality data in the Netherlands using the cardiovascular registry Maastricht cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Evaluation of cardiovascular risk predicted by different SCORE equations: the Netherlands as an example

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Applying Cox regression to competing risks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Use and misuse of the receiver operating characteristic curve in risk prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Quality of hospital and outpatient care after stroke or transient ischemic attack: insights from a stroke survey in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

How much does HDL cholesterol add to risk estimation? A report from the SCORE Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Systematic review of guidelines on cardiovascular risk assessment: Which recommendations should clinicians follow for a cardiovascular health check?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Systematic Examination of the Updated Framingham Heart Study General Cardiovascular Risk Profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Cohort Profile: The EPIC-NL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

Response to Conroy et al. SCORE Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487312443485

21 January 2018

Identifiers

DOI

10.1177/2047487312443485

1 reference

31 July 2017

1 reference

PubMed ID

22441305